Although regular monitoring of levothyroxine doses is indicated, 7 8 evidence suggests that the dose often remains unchanged as people age, 9 10 and over 20% of older adults are overtreated, 11 12 13 14 leading to iatrogenic hyperthyroidism.
Although not compulsory, monitoring of patient doses and comparisons to national values are routinely recommended [41] and perhaps mandatory reporting of CT doses within the diagnostic report would increase the use of this important optimisation tool.
Monitoring of individual dose exposure is mandatory along with feedback of the cumulative dose.
Given the complexity of treating AKI patients and handling the extracorporeal system, highly efficient CRRT management, which includes proper exchange of extracorporeal circuits, frequent monitoring for dose of CRRT, and optimal anticoagulation and replacement of electrolytes, are regarded as potential candidates for improving patient outcomes [ 9, 11].
Ionic dialysance can provide accurate monitoring of dialysis dose during each hemodialysis session.
The monitoring of the dose administrated and received in radiotherapy is also needed as the possibility of radiation induced cancer exists for patients exposed intentionally to radiation.
MOS C V methods are widely used for process ramp up and monitoring and MOS C V doping profiling is an introduced method for monitoring of low dose implants.
Ongoing monitoring of levothyroxine dose is important to avoid overtreatment in this population.
With the support of healthcare providers, patients should also be involved in the ongoing monitoring and adjustment of doses.
The applicability of the spore dosimetry for continuous long-term monitoring of biologically effective doses of solar-UV radiation has been verified in this work.
